← 產業報告目錄
Predictive Disease Analytics Market Size, Share & Trends Analysis Report By Component (Hardware, Software & Services), By Deployment (On-premise and Cloud-based), By End-user (Healthcare Providers, Healthcare Payers), By Region, And Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-01頁數 180報告編號 INSIGHTACE-780add204f
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
The Predictive Disease Analytics Market on a global scale was estimated at USD 3.3 Bn in 2024 and is forecasted to attain USD 22.6 Bn by 2034, with a projected CAGR of 21.2% between 2025 and 2034.
Predictive Disease Analytics encompasses challenges.
Several factors contribute to this trajectory, including heightened requirement next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
Through rigorous analysis of market trends, growth catalysts, restraints, and opportunities, this study offers valuable perspectives for companies, investors, and policymakers navigating this evolving landscape.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Predictive Disease Analytics Market Snapshot
Chapter 4. Global Predictive Disease Analytics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Component Estimates & Trend Analysis
5.1. by Component & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Component:
5.2.1. Software and Services
5.2.2. Hardware
Chapter 6. Market Segmentation 2: by Deployment Estimates & Trend Analysis
6.1. by Deployment & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Deployment:
6.2.1. On-premise
6.2.2. Cloud-based
Chapter 7. Market Segmentation 3: by End-user Estimates & Trend Analysis
7.1. by End-user & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-user:
7.2.1. Healthcare Payers
7.2.2. Healthcare Providers
7.2.3. Other End-Users
Chapter 8. Predictive Disease Analytics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.1.2. North America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.1.3. North America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.1.4. North America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.2. Europe
8.2.1. Europe Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.2.2. Europe Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.2.3. Europe Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.2.4. Europe Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.3. Asia Pacific
8.3.1. Asia Pacific Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.3.2. Asia Pacific Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.3.3. Asia-Pacific Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.3.4. Asia Pacific Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.4. Latin America
8.4.1. Latin America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.4.2. Latin America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.4.3. Latin America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.4.4. Latin America Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
8.5. Middle East & Africa
8.5.1. Middle East & Africa Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Component, 2021-2034
8.5.2. Middle East & Africa Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by Deployment, 2021-2034
8.5.3. Middle East & Africa Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by End-user, 2021-2034
8.5.4. Middle East & Africa Predictive Disease Analytics Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Oracle
9.2.2. IBM
9.2.3. SAS
9.2.4. Allscripts Healthcare Solutions Inc.
9.2.5. MedeAnalytics, Inc.
9.2.6. Health Catalyst
9.2.7. Apixio Inc.
9.2.8. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們